TGTX logo

TG Therapeutics, Inc. (TGTX) Depreciation and amortization

annual D&A:

$280.00K-$143.00K(-33.81%)
December 31, 2024

Summary

  • As of today (September 17, 2025), TGTX annual depreciation & amortization is $280.00 thousand, with the most recent change of -$143.00 thousand (-33.81%) on December 31, 2024.
  • During the last 3 years, TGTX annual D&A has fallen by -$214.00 thousand (-43.32%).
  • TGTX annual D&A is now -45.63% below its all-time high of $515.00 thousand, reached on December 31, 2022.

Performance

TGTX Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXincome statement metrics

quarterly D&A:

$59.00K+$3000.00(+5.36%)
June 30, 2025

Summary

  • As of today (September 17, 2025), TGTX quarterly depreciation & amortization is $59.00 thousand, with the most recent change of +$3000.00 (+5.36%) on June 30, 2025.
  • Over the past year, TGTX quarterly D&A has dropped by -$13.00 thousand (-18.06%).
  • TGTX quarterly D&A is now -97.17% below its all-time high of $2.08 million, reached on March 31, 2020.

Performance

TGTX quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXincome statement metrics

TTM D&A:

$241.00K-$13.00K(-5.12%)
June 30, 2025

Summary

  • As of today (September 17, 2025), TGTX TTM depreciation & amortization is $241.00 thousand, with the most recent change of -$13.00 thousand (-5.12%) on June 30, 2025.
  • Over the past year, TGTX TTM D&A has dropped by -$130.00 thousand (-35.04%).
  • TGTX TTM D&A is now -89.72% below its all-time high of $2.34 million, reached on March 31, 2020.

Performance

TGTX TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXincome statement metrics

TGTX Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-33.8%-18.1%-35.0%
3 y3 years-43.3%-55.0%-53.8%
5 y5 years-0.7%+103.1%-41.2%

TGTX Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-45.6%at low-55.0%+5.4%-53.8%at low
5 y5-year-45.6%at low-55.6%+103.1%-53.8%+115.1%
alltimeall time-45.6%>+9999.0%-97.2%+103.1%-89.7%+115.1%

TGTX Depreciation and amortization History

DateAnnualQuarterlyTTM
Jun 2025
-
$59.00K(+5.4%)
$241.00K(-5.1%)
Mar 2025
-
$56.00K(-9.7%)
$254.00K(-9.3%)
Dec 2024
$280.00K(-33.8%)
$62.00K(-3.1%)
$280.00K(-9.4%)
Sep 2024
-
$64.00K(-11.1%)
$309.00K(-16.7%)
Jun 2024
-
$72.00K(-12.2%)
$371.00K(-3.4%)
Mar 2024
-
$82.00K(-9.9%)
$384.00K(-9.2%)
Dec 2023
$423.00K(-17.9%)
$91.00K(-27.8%)
$423.00K(-7.6%)
Sep 2023
-
$126.00K(+48.2%)
$458.00K(-0.7%)
Jun 2023
-
$85.00K(-29.8%)
$461.00K(-9.1%)
Mar 2023
-
$121.00K(-4.0%)
$507.00K(-1.6%)
Dec 2022
$515.00K(+4.3%)
$126.00K(-2.3%)
$515.00K(-1.3%)
Sep 2022
-
$129.00K(-1.5%)
$522.00K(0.0%)
Jun 2022
-
$131.00K(+1.6%)
$522.00K(+2.2%)
Mar 2022
-
$129.00K(-3.0%)
$511.00K(+3.4%)
Dec 2021
$494.00K(+32.1%)
$133.00K(+3.1%)
$494.00K(+5.8%)
Sep 2021
-
$129.00K(+7.5%)
$467.00K(+8.1%)
Jun 2021
-
$120.00K(+7.1%)
$432.00K(-127.0%)
Mar 2021
-
$112.00K(+5.7%)
-$1.60M(-527.5%)
Dec 2020
$374.00K(+32.6%)
$106.00K(+12.8%)
$374.00K(+9.7%)
Sep 2020
-
$94.00K(-104.9%)
$341.00K(-16.8%)
Jun 2020
-
-$1.91M(-191.7%)
$410.00K(-82.5%)
Mar 2020
-
$2.08M(+2756.2%)
$2.34M(+731.2%)
Dec 2019
$282.00K(+220.5%)
$73.00K(-55.2%)
$282.00K(+21.0%)
Sep 2019
-
$163.00K(+608.7%)
$233.00K(+150.5%)
Jun 2019
-
$23.00K(0.0%)
$93.00K(+2.2%)
Mar 2019
-
$23.00K(-4.2%)
$91.00K(+3.4%)
Dec 2018
$88.00K(+6.8%)
$24.00K(+4.3%)
$88.00K(+4.4%)
Sep 2018
-
$23.00K(+9.5%)
$84.30K(+2.4%)
Jun 2018
-
$21.00K(+5.0%)
$82.30K(0.0%)
Mar 2018
-
$20.00K(-1.5%)
$82.30K(0.0%)
Dec 2017
$82.40K(+30.8%)
$20.30K(-3.3%)
$82.30K(-0.2%)
Sep 2017
-
$21.00K(0.0%)
$82.50K(+2.4%)
Jun 2017
-
$21.00K(+5.0%)
$80.60K(+5.4%)
Mar 2017
-
$20.00K(-2.4%)
$76.50K(+21.6%)
Dec 2016
$63.00K(+306.5%)
$20.50K(+7.3%)
$62.90K(+32.4%)
Sep 2016
-
$19.10K(+13.0%)
$47.50K(+44.4%)
Jun 2016
-
$16.90K(+164.1%)
$32.90K(+69.6%)
Mar 2016
-
$6400.00(+25.5%)
$19.40K(+26.0%)
Dec 2015
$15.50K(+297.4%)
$5100.00(+13.3%)
$15.40K(+30.5%)
Sep 2015
-
$4500.00(+32.4%)
$11.80K(+43.9%)
Jun 2015
-
$3400.00(+41.7%)
$8200.00(+43.9%)
Mar 2015
-
$2400.00(+60.0%)
$5700.00(+42.5%)
Dec 2014
$3900.00(+254.5%)
$1500.00(+66.7%)
$4000.00(+33.3%)
Sep 2014
-
$900.00(0.0%)
$3000.00(+25.0%)
Jun 2014
-
$900.00(+28.6%)
$2400.00(+41.2%)
Mar 2014
-
$700.00(+40.0%)
$1700.00(+54.5%)
Dec 2013
$1100.00(+450.0%)
$500.00(+66.7%)
$1100.00(+57.1%)
Sep 2013
-
$300.00(+50.0%)
$700.00(+75.0%)
Jun 2013
-
$200.00(+100.0%)
$400.00(+100.0%)
Mar 2013
-
$100.00(0.0%)
$200.00(+100.0%)
Dec 2012
$200.00
$100.00(-107.1%)
$100.00(>+9900.0%)
Dec 2011
-
-$1400.00(-800.0%)
$0.00(-100.0%)
Sep 2011
-
$200.00(-50.0%)
$2200.00(-4.3%)
Jun 2011
-
$400.00(-50.0%)
$2300.00(-34.3%)
DateAnnualQuarterlyTTM
Mar 2011
-
$800.00(0.0%)
$3500.00(0.0%)
Dec 2010
$3400.00(-38.2%)
$800.00(+166.7%)
$3500.00(-10.3%)
Sep 2010
-
$300.00(-81.3%)
$3900.00(-18.8%)
Jun 2010
-
$1600.00(+100.0%)
$4800.00(+2.1%)
Mar 2010
-
$800.00(-33.3%)
$4700.00(-14.5%)
Dec 2009
$5500.00(-78.9%)
$1200.00(0.0%)
$5500.00(-22.5%)
Sep 2009
-
$1200.00(-20.0%)
$7100.00(-47.4%)
Jun 2009
-
$1500.00(-6.3%)
$13.50K(-31.5%)
Mar 2009
-
$1600.00(-42.9%)
$19.70K(-24.2%)
Dec 2008
$26.10K(-46.0%)
$2800.00(-63.2%)
$26.00K(-16.4%)
Sep 2008
-
$7600.00(-1.3%)
$31.10K(-8.3%)
Jun 2008
-
$7700.00(-2.5%)
$33.90K(-15.9%)
Mar 2008
-
$7900.00(0.0%)
$40.30K(-16.6%)
Dec 2007
$48.30K(-19.8%)
$7900.00(-24.0%)
$48.30K(-13.8%)
Sep 2007
-
$10.40K(-26.2%)
$56.00K(-7.7%)
Jun 2007
-
$14.10K(-11.3%)
$60.70K(-0.8%)
Mar 2007
-
$15.90K(+1.9%)
$61.20K(+1.7%)
Dec 2006
$60.20K(+12.1%)
$15.60K(+3.3%)
$60.20K(+3.6%)
Sep 2006
-
$15.10K(+3.4%)
$58.10K(+3.9%)
Jun 2006
-
$14.60K(-2.0%)
$55.90K(0.0%)
Mar 2006
-
$14.90K(+10.4%)
$55.90K(+4.1%)
Dec 2005
$53.70K(+96.7%)
$13.50K(+4.7%)
$53.70K(+3.9%)
Sep 2005
-
$12.90K(-11.6%)
$51.70K(+9.3%)
Jun 2005
-
$14.60K(+15.0%)
$47.30K(+25.8%)
Mar 2005
-
$12.70K(+10.4%)
$37.60K(+37.2%)
Dec 2004
$27.30K(-82.0%)
$11.50K(+35.3%)
$27.40K(+53.1%)
Sep 2004
-
$8500.00(+73.5%)
$17.90K(-64.8%)
Jun 2004
-
$4900.00(+96.0%)
$50.90K(-59.9%)
Mar 2004
-
$2500.00(+25.0%)
$127.00K(-16.1%)
Dec 2003
$151.40K(+205.9%)
$2000.00(-95.2%)
$151.40K(-6.4%)
Sep 2003
-
$41.50K(-48.8%)
$161.80K(+21.4%)
Jun 2003
-
$81.00K(+201.1%)
$133.30K(+104.4%)
Mar 2003
-
$26.90K(+116.9%)
$65.20K(+31.7%)
Dec 2002
$49.50K(-25.2%)
$12.40K(-4.6%)
$49.50K(+2.5%)
Sep 2002
-
$13.00K(+0.8%)
$48.30K(+4.1%)
Jun 2002
-
$12.90K(+15.2%)
$46.40K(-8.1%)
Mar 2002
-
$11.20K(0.0%)
$50.50K(-23.7%)
Dec 2001
$66.20K(-13.0%)
$11.20K(+0.9%)
$66.20K(-16.8%)
Sep 2001
-
$11.10K(-34.7%)
$79.60K(-8.8%)
Jun 2001
-
$17.00K(-36.8%)
$87.30K(0.0%)
Mar 2001
-
$26.90K(+9.3%)
$87.30K(+14.6%)
Dec 2000
$76.10K(-33.1%)
$24.60K(+30.9%)
$76.20K(+2.3%)
Sep 2000
-
$18.80K(+10.6%)
$74.50K(-13.4%)
Jun 2000
-
$17.00K(+7.6%)
$86.00K(-13.4%)
Mar 2000
-
$15.80K(-31.0%)
$99.30K(-12.7%)
Dec 1999
$113.80K(-31.7%)
$22.90K(-24.4%)
$113.80K(-14.9%)
Sep 1999
-
$30.30K(0.0%)
$133.80K(-8.6%)
Jun 1999
-
$30.30K(0.0%)
$146.40K(-7.9%)
Mar 1999
-
$30.30K(-29.4%)
$159.00K(-4.6%)
Dec 1998
$166.60K(+66.6%)
$42.90K(0.0%)
$166.60K(+34.7%)
Sep 1998
-
$42.90K(0.0%)
$123.70K(+53.1%)
Jun 1998
-
$42.90K(+13.2%)
$80.80K(+113.2%)
Mar 1998
-
$37.90K
$37.90K
Dec 1997
$100.00K
-
-

FAQ

  • What is TG Therapeutics, Inc. annual depreciation & amortization?
  • What is the all time high annual D&A for TG Therapeutics, Inc.?
  • What is TG Therapeutics, Inc. annual D&A year-on-year change?
  • What is TG Therapeutics, Inc. quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for TG Therapeutics, Inc.?
  • What is TG Therapeutics, Inc. quarterly D&A year-on-year change?
  • What is TG Therapeutics, Inc. TTM depreciation & amortization?
  • What is the all time high TTM D&A for TG Therapeutics, Inc.?
  • What is TG Therapeutics, Inc. TTM D&A year-on-year change?

What is TG Therapeutics, Inc. annual depreciation & amortization?

The current annual D&A of TGTX is $280.00K

What is the all time high annual D&A for TG Therapeutics, Inc.?

TG Therapeutics, Inc. all-time high annual depreciation & amortization is $515.00K

What is TG Therapeutics, Inc. annual D&A year-on-year change?

Over the past year, TGTX annual depreciation & amortization has changed by -$143.00K (-33.81%)

What is TG Therapeutics, Inc. quarterly depreciation & amortization?

The current quarterly D&A of TGTX is $59.00K

What is the all time high quarterly D&A for TG Therapeutics, Inc.?

TG Therapeutics, Inc. all-time high quarterly depreciation & amortization is $2.08M

What is TG Therapeutics, Inc. quarterly D&A year-on-year change?

Over the past year, TGTX quarterly depreciation & amortization has changed by -$13.00K (-18.06%)

What is TG Therapeutics, Inc. TTM depreciation & amortization?

The current TTM D&A of TGTX is $241.00K

What is the all time high TTM D&A for TG Therapeutics, Inc.?

TG Therapeutics, Inc. all-time high TTM depreciation & amortization is $2.34M

What is TG Therapeutics, Inc. TTM D&A year-on-year change?

Over the past year, TGTX TTM depreciation & amortization has changed by -$130.00K (-35.04%)
On this page